Dexcom (DXCM)

R&D Expenses

$153.00M

Quarterly · Period ending: · USD

DXCM logo

DXCM R&D Expenses

Latest reported$153.00M
DXCM Quarterly R&D Expenses ($5.44M → $153.00M)
High-resolution chart · PNG

DXCM r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
153,000,000
145,300,000
148,200,000
157,500,000
148,200,000
145,200,000
139,500,000
135,400,000
136,000,000
141,500,000
136,100,000
131,400,000
119,300,000
119,000,000
116,300,000
110,300,000
121,700,000
135,900,000
236,900,000
128,800,000
129,100,000
109,400,000
119,200,000
87,700,000
79,900,000
73,100,000
78,800,000
66,700,000
69,000,000
59,000,000
275,300,000
50,100,000
47,200,000
44,800,000
48,700,000
43,300,000
45,300,000
48,100,000
43,700,000
43,900,000
36,300,000
32,200,000
28,500,000
64,800,000
24,400,000
19,800,000
21,600,000
18,500,000
14,800,000
14,500,000
12,600,000
11,800,000
11,100,000
9,300,000
8,705,000
10,582,000
10,498,000
9,715,000
9,232,000
8,231,000
7,016,000
6,268,000
6,902,000
6,161,000
5,425,000
4,739,000
4,172,000
3,496,000
3,455,000
3,171,000
4,571,000
5,418,000
4,797,000
4,843,000
4,397,000
3,671,000
4,028,000
4,035,000
3,929,888
4,634,157
5,361,419
5,494,085
10,945,876
5,042,993
4,978,718
5,435,077
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.